B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells (Q42912844)

11 November 2017

B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells (English)

1 reference

11 November 2017

1 reference

7

1 reference

11 November 2017

E Gross

1

1 reference

11 November 2017

F-E L'Faqihi-Olive

2

1 reference

11 November 2017

L Ysebaert

3

1 reference

11 November 2017

M Brassac

4

1 reference

11 November 2017

S Struski

5

1 reference

11 November 2017

S Kheirallah

6

1 reference

11 November 2017

G Laurent

8

1 reference

11 November 2017

A Quillet-Mary

9

1 reference

11 November 2017

9 September 2010

1 reference

11 November 2017

1 reference

11 November 2017

24

1 reference

11 November 2017

11

1 reference

11 November 2017

1885-1892

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2010.176

11 November 2017

0 references

cites work

Further progress in CLL therapy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Treatment of relapsed chronic lymphocytic leukemia: old and new therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Elevated Bcl-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Erratum to: Functional and molecular characterisation of mammary side population cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Cellular and molecular regulation of skeletal muscle side population cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Side population and cancer stem cells: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Side population cells in human and mouse epidermis lack stem cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

From pathogenesis to treatment of chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

SP analysis may be used to identify cancer stem cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

Chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

7 January 2021

Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

7 January 2021

Functional and molecular characterisation of mammary side population cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

7 January 2021

Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.176

7 January 2021

Identifiers

DOI

10.1038/LEU.2010.176

1 reference

Dimensions Publication ID

11 November 2017

0 references

1 reference